Member spotlight of the day

Vaderis Therapeutics AG

Vaderis Therapeutics AG is a clinical stage biotech focussing on treatment of rare diseases caused by vascular malformations.  The company was founded in 2019 in Basel, Switzerland, and closed a Series A investment of CHF18.1Mio in 2020.  

Employees in Switzerland
1–9
Founded
2020